Since glioblastoma, medulloblastoma, and neuroblastoma tumors show high expression of cyclooxygenase-2 (COX-2) and nonsteroidal anti-inflammatory drugs (NSAIDs) levels, COX-2 and PGE2 inhibitors possess a profound effect on tumor growth. Here, PTGS2 is linked to medulloblastoma.